Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
MADISON, Wis.--(BUSINESS WIRE)--Feb 28, 2024--
28.02.2024 - Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the launch of the Riskguard hereditary cancer test in the United States. The Riskguard test provides an individualized patient report that includes ... Seite 1